Vagina injection agent for treating uterine prolapse and preparation method of vagina injection agent
A technology for uterine prolapse and injection, which is applied in the field of medicine, can solve the problems of pessary that cannot achieve a radical effect, low content of active ingredients, and great influence on patients, and achieves the effects of improving vaginal microenvironment, high drug concentration, and difficulty in recurrence.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] A vaginal injection for treating uterine prolapse, which consists of the following components by weight: 13 parts of β-glucan, 5 parts of Lycium barbarum polysaccharide, 5 parts of chitosan oligosaccharide, 10 parts of recombinant human serum albumin, 10 parts of recombinant human 0.3 parts of interleukin-22, 0.3 parts of recombinant human interleukin-4, 1 part of recombinant human epidermal growth factor, 12 parts of active lactic acid bacteria powder, 0.5 parts of penetration enhancer, 3 parts of bioadhesive agent, 50 parts of buffer And 80 parts of normal saline.
[0030] The active lactic acid bacteria powder is composed of Lactobacillus bulgaricus powder, Lactobacillus acidophilus powder and Lactobacillus salivarius powder, and by mass ratio, Lactobacillus bulgaricus powder: Lactobacillus acidophilus powder: Lactobacillus salivarius powder=1:1:4 .
Embodiment 2
[0032] A vaginal injection for treating uterine prolapse, which consists of the following components by weight: 5 parts of oat β-glucan, 10 parts of wolfberry polysaccharide, 8 parts of chitosan oligosaccharide, 15 parts of recombinant human serum albumin, recombinant 0.5 parts of human interleukin-22, 0.2 parts of recombinant human interleukin-4, 0.3 parts of recombinant human epidermal growth factor, 15 parts of active lactic acid bacteria powder, 0.6 parts of water-soluble azone, 4 parts of sodium carboxymethyl cellulose, 60 parts of sodium acetate-acetic acid buffer solution (pH=4.5) and 50 parts of normal saline.
[0033] The active lactic acid bacteria powder is composed of Lactobacillus bulgaricus powder, Lactobacillus acidophilus powder and Lactobacillus salivarius powder, and by mass ratio, Lactobacillus bulgaricus powder: Lactobacillus acidophilus powder: Lactobacillus salivarius powder=1:1:4 .
Embodiment 3
[0035] A vaginal injection for treating uterine prolapse, which consists of the following components by weight: 10 parts of oat β-glucan, 1 part of wolfberry polysaccharide, 10 parts of chitosan oligosaccharide, 12 parts of recombinant human serum albumin, recombinant 0.4 parts of human interleukin-22, 0.4 parts of recombinant human interleukin-4, 1 part of recombinant human epidermal growth factor, 11 parts of active lactic acid bacteria powder, 1 part of water-soluble azone, 5 parts of sodium carboxymethyl cellulose, 60 parts of sodium acetate-acetic acid buffer (pH=4.5) and 60 parts of normal saline.
[0036] The active lactic acid bacteria powder is composed of Lactobacillus bulgaricus powder, Lactobacillus acidophilus powder and Lactobacillus salivarius powder, and by mass ratio, Lactobacillus bulgaricus powder: Lactobacillus acidophilus powder: Lactobacillus salivarius powder=1:1:4 .
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com